117 related articles for article (PubMed ID: 10853992)
1. Detection of drug-selected mutations in HIV-1 subtype E reverse transcriptase sequence using the line probe assay.
Lee CC; Thoe SY; Leo YS; Chan KP; Ling AE
AIDS; 2000 May; 14(8):1064-5. PubMed ID: 10853992
[No Abstract] [Full Text] [Related]
2. Identification of reverse transcriptase mutations associated with HIV-1 drug resistance mainly against non-nucleoside reverse transcriptase inhibitors in treatment-naive patients.
Magiorkinis E; Paraskevis D; Lazanas M; Kiosses VG; Gargalianos P; Hatzakis A
AIDS; 1999 Jul; 13(10):1276-8. PubMed ID: 10416535
[No Abstract] [Full Text] [Related]
3. Comparative evaluation of three human immunodeficiency virus genotyping systems: the HIV-GenotypR method, the HIV PRT GeneChip assay, and the HIV-1 RT line probe assay.
Wilson JW; Bean P; Robins T; Graziano F; Persing DH
J Clin Microbiol; 2000 Aug; 38(8):3022-8. PubMed ID: 10921971
[TBL] [Abstract][Full Text] [Related]
4. Detection of drug resistance associated mutations in HIV primary infection within the UK.
Pillay D; Cane PA; Shirley J; Porter K
AIDS; 2000 May; 14(7):906-8. PubMed ID: 10839606
[No Abstract] [Full Text] [Related]
5. Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid.
Cunningham PH; Smith DG; Satchell C; Cooper DA; Brew B
AIDS; 2000 Sep; 14(13):1949-54. PubMed ID: 10997399
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 drug resistance in newly infected individuals.
Boden D; Hurley A; Zhang L; Cao Y; Guo Y; Jones E; Tsay J; Ip J; Farthing C; Limoli K; Parkin N; Markowitz M
JAMA; 1999 Sep 22-29; 282(12):1135-41. PubMed ID: 10501116
[TBL] [Abstract][Full Text] [Related]
7. Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo.
de Baar MP; Janssens W; de Ronde A; Fransen K; Colebunders R; Kestens L; van der Groen G; Goudsmit J
AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1385-94. PubMed ID: 11018858
[TBL] [Abstract][Full Text] [Related]
8. Reverse transcriptase fidelity and HIV-1 variation.
Balzarini J; Pelemans H; De Clercq E; Karlsson A; Kleim JP
Science; 1997 Jan; 275(5297):229-30; author reply 230-1. PubMed ID: 8999551
[No Abstract] [Full Text] [Related]
9. Reverse transcriptase fidelity and HIV-1 variation.
Preston BD
Science; 1997 Jan; 275(5297):228-9; author reply 230-1. PubMed ID: 8999549
[No Abstract] [Full Text] [Related]
10. Reverse transcriptase fidelity and HIV-1 variation.
Keulen W; Nijhuis M; Schuurman R; Berkhout B; Boucher C
Science; 1997 Jan; 275(5297):229; author reply 230-1. PubMed ID: 8999550
[No Abstract] [Full Text] [Related]
11. Evolution of HIV-1 multidrug-resistant genotypes during combination therapy and after the cessation of antiretroviral drugs.
Yahi N; Tourrès C; Tivoli N; Colson P; Dhiver C; Quinson AM; Tamalet C
AIDS; 2000 Dec; 14(18):2943-5. PubMed ID: 11153678
[No Abstract] [Full Text] [Related]
12. R211K and L214F do not invariably confer high level phenotypic resistance to thymidine analogs in zidovudine-naive patients with M184V.
Torti C; Gilleece Y; Hertogs K; Gazzard BG; Pozniak AL
J Acquir Immune Defic Syndr; 2001 Apr; 26(5):514-5. PubMed ID: 11391177
[No Abstract] [Full Text] [Related]
13. Infection by zidovudine-resistant HIV-1 compromises the virological response to stavudine in a drug-naive patient.
de Ronde A; van Dooren M; de Rooij E; van Gemen B; Lange J; Goudsmit J
AIDS; 2000 Nov; 14(16):2632-3. PubMed ID: 11101087
[No Abstract] [Full Text] [Related]
14. Nucleoside reverse transcriptase inhibitor resistance mutations in subtype F1 strains isolated from heavily treated adolescents in Romania.
Paraschiv S; Otelea D; Baicus C; Tinischi M; Costache M; Neaga E
Int J Infect Dis; 2009 Jan; 13(1):81-9. PubMed ID: 18632295
[TBL] [Abstract][Full Text] [Related]
15. Comparison of sequencing by hybridization and cycle sequencing for genotyping of human immunodeficiency virus type 1 reverse transcriptase.
Hanna GJ; Johnson VA; Kuritzkes DR; Richman DD; Martinez-Picado J; Sutton L; Hazelwood JD; D'Aquila RT
J Clin Microbiol; 2000 Jul; 38(7):2715-21. PubMed ID: 10878069
[TBL] [Abstract][Full Text] [Related]
16. Highly active antiretroviral therapy failure and protease and reverse transcriptase human immunodeficiency virus type 1 gene mutations.
Monno L; Appice A; Cavaliere R; Scarabaggio T; Angarano G
J Infect Dis; 1999 Aug; 180(2):568-71. PubMed ID: 10395885
[No Abstract] [Full Text] [Related]
17. Antiretroviral Resistance Mutations (revised April 2001).
;
HIV Clin Trials; 2001; 2(4):346-55. PubMed ID: 11590539
[No Abstract] [Full Text] [Related]
18. Line probe assay for detection of human immunodeficiency virus type 1 mutations conferring resistance to nucleoside inhibitors of reverse transcriptase: comparison with sequence analysis.
Descamps D; Calvez V; Collin G; Cécille A; Apetrei C; Damond F; Katlama C; Matheron S; Huraux JM; Brun-Vézinet F
J Clin Microbiol; 1998 Jul; 36(7):2143-5. PubMed ID: 9650987
[TBL] [Abstract][Full Text] [Related]
19. Current insights into reverse transcriptase inhibitor-associated resistance.
Wainberg MA; White AJ
Antivir Ther; 2001; 6 Suppl 2():11-9. PubMed ID: 11678474
[No Abstract] [Full Text] [Related]
20. Prevalence of the K65R resistance reverse transcriptase mutation in different HIV-1 subtypes in Israel.
Turner D; Shahar E; Katchman E; Kedem E; Matus N; Katzir M; Hassoun G; Pollack S; Kessner R; Wainberg MA; Avidor B
J Med Virol; 2009 Sep; 81(9):1509-12. PubMed ID: 19626612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
